Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 382-385

  de Vrankrijker, A M M ^a   Brimicombe, R W ^b   Wolfs, T F W ^a   Heijerman, H G M ^b   Van Mansfeld, R ^a   Van Berkhout, F T ^a   Willems, R J L ^a   Bonten, M J M ^a   Van Der Ent, C K ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

Clone; Cross infection; Cystic fibrosis; MLST; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLONE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE TRANSMISSION; ETHNIC GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD;

PSEUDOMONAS AERUGINOSA;

EID: 79751476608     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03295.x     Document Type: Article

References (20)

1. Pressler T, Frederiksen B, Skov M et al. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection-a case control study. J Cyst Fibros 2006; 5: 9-15.
2. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990; 116: 714-719.
3. Kelly NM, Fitzgerald MX, Tempany E et al. Does Pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet 1982; 2: 688-690.
4. Armstrong DS, Nixon GM, Carzino R et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002; 166: 983-987.
5. Jones AM, Dodd ME, Doherty CJ, Govan JR, Webb AK. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 2002; 57: 924-925.
6. Al-Aloul M, Crawley J, Winstanley C et al. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004; 59: 334-336.
7. O'Carroll MR, Syrmis MW, Wainwright CE et al. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004; 24: 101-106.
8. Griffiths AL, Jamsen K, Carlin JB et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005; 171: 1020-1025.
9. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 2003; 31: S1-S62.
10. Cystic Fibrosis Trust Infection Control Group. Pseudomonas aeruginosa infection in people with cystic fibrosis. 2004.
11. van Mansfeld R, Willems R, Brimicombe R et al. Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. J Clin Microbiol 2009; 47: 4096-4101.
12. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003; 361: 1671-1676.
13. Kosorok MR, Zeng L, West SE et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001; 32: 277-287.
14. Cheng K, Smyth RL, Govan JR et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348: 639-642.
15. Jones AM, Dodd ME, Morris J et al. Clinical outcome for cystic fibrosis patients infected with transmissible P. aeruginosa: an 8 year prospective study. Chest 2010; 137: 1405-1409.
16. Salunkhe P, Smart CH, Morgan JA et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005; 187: 4908-4920.
17. Manos J, Arthur J, Rose B et al. Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. J Med Microbiol 2008; 57: 1454-1465.
18. Tingpej P, Smith L, Rose B et al. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 2007; 45: 1697-1704.
19. Jelsbak L, Johansen HK, Frost AL et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007; 75: 2214-2224.
20. Brimicombe RW, Dijkshoorn L, van der Reijden TJ et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2008; 7: 30-36.